chr16-2084417-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000548.5(TSC2):​c.4195G>A​(p.Gly1399Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000212 in 1,611,108 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G1399V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0012 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

TSC2
NM_000548.5 missense

Scores

1
8
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16O:2

Conservation

PhyloP100: 2.75

Publications

12 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007953197).
BP6
Variant 16-2084417-G-A is Benign according to our data. Variant chr16-2084417-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 50062.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00118 (180/152362) while in subpopulation AFR AF = 0.00397 (165/41588). AF 95% confidence interval is 0.00347. There are 1 homozygotes in GnomAd4. There are 87 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 180 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.4195G>Ap.Gly1399Arg
missense
Exon 34 of 42NP_000539.2P49815-1
TSC2
NM_001406663.1
c.4192G>Ap.Gly1398Arg
missense
Exon 34 of 42NP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.4126G>Ap.Gly1376Arg
missense
Exon 33 of 41NP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.4195G>Ap.Gly1399Arg
missense
Exon 34 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.4126G>Ap.Gly1376Arg
missense
Exon 33 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.3994G>Ap.Gly1332Arg
missense
Exon 32 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.00119
AC:
181
AN:
152244
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00400
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000589
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000332
AC:
81
AN:
244278
AF XY:
0.000316
show subpopulations
Gnomad AFR exome
AF:
0.00465
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000110
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000910
Gnomad OTH exome
AF:
0.000167
GnomAD4 exome
AF:
0.000110
AC:
161
AN:
1458746
Hom.:
0
Cov.:
33
AF XY:
0.000110
AC XY:
80
AN XY:
725580
show subpopulations
African (AFR)
AF:
0.00368
AC:
123
AN:
33426
American (AMR)
AF:
0.000179
AC:
8
AN:
44598
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26080
East Asian (EAS)
AF:
0.0000505
AC:
2
AN:
39592
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85880
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51754
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000144
AC:
16
AN:
1111336
Other (OTH)
AF:
0.000199
AC:
12
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00118
AC:
180
AN:
152362
Hom.:
1
Cov.:
34
AF XY:
0.00117
AC XY:
87
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.00397
AC:
165
AN:
41588
American (AMR)
AF:
0.000588
AC:
9
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000742
Hom.:
0
Bravo
AF:
0.00132
ESP6500AA
AF:
0.00297
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000381
AC:
46

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (7)
-
-
4
Tuberous sclerosis 2 (4)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not provided (2)
-
-
2
Tuberous sclerosis syndrome (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.050
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D
Eigen
Benign
-0.12
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.36
N
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.44
D
MetaRNN
Benign
0.0080
T
MetaSVM
Benign
-0.40
T
MutationAssessor
Benign
1.6
L
PhyloP100
2.8
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.8
N
REVEL
Uncertain
0.44
Sift
Uncertain
0.015
D
Sift4G
Uncertain
0.023
D
Polyphen
0.86
P
Vest4
0.35
MutPred
0.10
Loss of relative solvent accessibility (P = 0.107)
MVP
0.88
ClinPred
0.026
T
GERP RS
2.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.065
gMVP
0.29
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45466399; hg19: chr16-2134418; COSMIC: COSV51911999; API